共 50 条
- [23] Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
- [24] Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study The Journal of Headache and Pain, 2022, 23
- [28] Eptinezumab for migraine prevention in patients with 2-4 prior treatment failures: DELIVER subpopulation analysis HEADACHE, 2022, 62 : 145 - 145
- [29] Long-term safety and effectiveness of eptinezumab in patients with prior preventive migraine treatment failures JOURNAL OF HEADACHE AND PAIN, 2024, 25